Well look at BCAAs and glutamine in some detail a little later
When taking GLP-1 medications (agonists) for type 2 diabetes or weight management, knowing what to eat is essential
It helps providers identify metabolic risks, screen for contraindications, and guide dosing decisions, particularly in patients with complex medical histories
Applied immediately after ketamine, it exhibited effects on NOS-1 (decreased expression), NOS-2 (increased expression), Plcg1 (decreased expression), Prkcg (increased, and then decreased expression), and Ptgs2 (increased expression), and it had no effect on NOS-3 and Ptk2 [171]
Researchers found that patients who achieved the greatest reductions in body weight after starting GLP-1-based medications had substantially lower risks of conditions including obstructive sleep apnea, chronic kidney disease, osteoarthritis, and heart failure